Eye on FDA

DECEMBER 15, 2021

We are long gone from the days of being threatened by a rampant Alpha virus to having several successive variants. Today CDC provided important insight into the ability of the new variant to make headway with a highly vulnerable population when it released data on infections in the nursing home environment.

Vaccine 72

Vaccine Nurses Virus Treatment 72

The Pharma Data

JANUARY 11, 2021

million, will boost its vaccine rollout to now include health care workers, nursing home residents and staff, as well as those living in congregate settings such as assisted living or shelters. Herd immunity will be reached when the virus encounters enough people with immunity that it dies out. An official from the U.S.

Vaccine 52

Vaccine Virus Assisted Living Nurses 52

The Pharma Data

DECEMBER 17, 2020

These follow-on data provided the first definitive prospective evidence demonstrating anti-viral activity for a treatment regimen now available for COVID-19, and also further documented the ability of this treatment to decrease the need for further medical attention,” said George D. Have chronic kidney disease. Have diabetes.

Hospitals 52

Hospitals Production Clinical Trials Virus 52

The Pharma Data

JANUARY 12, 2021

. “Patients in our antibody cocktail outpatient clinical trial experienced significant reductions in virus levels and required fewer medical visits for COVID-19, suggesting the therapy can help reduce the current burden on hospitals and healthcare systems,” said George D. Definition of High-Risk Patients. Yancopoulos , M.D.,

Government 52

Government Hospitals Virus Production 52

The Pharma Data

DECEMBER 29, 2020

About Regeneron Antibody Cocktail Casirivimab and imdevimab is a cocktail of two monoclonal antibodies (also known as REGN10933 and REGN10987, respectively) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19.

Hospitals 52

Hospitals Trials Clinical Trials Production 52

The Pharma Data

SEPTEMBER 23, 2020

‘A scary time’ Clementine Stott, an organ donation specialist nurse at Worcester Royal Hospital, was redeployed to the intensive care unit during the first wave which, for her, meant separating from her 10-year-old son for seven weeks. “With the virus, we had to adapt to a totally different way of working,” she said.

Nurses 52

Nurses Hospitals Virus Government 52

The Pharma Data

NOVEMBER 20, 2020

“The casirivimab and imdevimab antibody cocktail is designed to mimic what a well-functioning immune system does by using very potent antibodies to neutralize the virus,” said George D. Definition of High-Risk Patients. Yancopoulos, M.D., President and Chief Scientific Officer of Regeneron. Have chronic kidney disease.

Therapies 52

Therapies FDA Clinical Trials Hospitals 52